Skip to main content
. 2022 Nov 29;13:996248. doi: 10.3389/fphys.2022.996248

FIGURE 4.

FIGURE 4

Metabolic pathway analysis of the screened differential markers. (A) Metabolic pathway analysis of differential metabolites between the RCC and BKT groups. (B) Metabolic pathway analysis of differential metabolites between the RCC and HC groups. (C) Metabolic pathway analysis of differential metabolites between the BKT and HC groups. HC, healthy control; BKT, benign kidney tumor; RCC, renal cell carcinoma; -log(P), negative logarithm of the p-value; Impact, impact value of metabolic pathway determined by topology analysis.